Home Newsfeeds BTIG Downgrades Taysha Gene Therapies to Neutral

BTIG Downgrades Taysha Gene Therapies to Neutral

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

byBenzinga Newsdesk

February 2, 2023

1 minute read

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

KLA Corp Stock Inches Higher Following Q1 Earnings – Here’s Why

By Ryan Gustafson

October 25, 4:58 PM

KLA Corporation (NASDAQ: KLAC) shares are trading higher in Wednesday's after-hours session on the heels of the company's first-quarter earnings results.

KLAC

Alabama Cannabis Saga: Judge Wants Quarrelling Parties To Get Along, Decision Expected Next Week

By Jelena Martinovic

August 29, 3:19 PM

An Alabama Cannabis Industry Association (AMCC) official urged those gathered in court on Monday to allow businesses that were awarded medical cannabis licenses to launch operations.

VRNOF

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

December 15, 1:46 PM

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.

AADI

Avalanche Flips Dogecoin To Capture Top 9 Crypto Ranking As Market Cap Hits Past $14B

By Mehab Qureshi

December 13, 11:47 PM

Avalanche (CRYPTO: AVAX) has eclipsed Dogecoin (CRYPTO: DOGE) to claim the ninth spot on CoinMarketCap’s leaderboard of the top 100 cryptocurrencies.

$AVAX

BTIG Downgrades Taysha Gene Therapies to Neutral

Related Posts

KLA Corp Stock Inches Higher Following Q1 Earnings – Here’s Why

Alabama Cannabis Saga: Judge Wants Quarrelling Parties To Get Along, Decision Expected Next Week

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Avalanche Flips Dogecoin To Capture Top 9 Crypto Ranking As Market Cap Hits Past $14B